Alzheon Appoints Chair
This article was originally published in Scrip
Executive Summary
Alzheon, Inc. has appointed former GlaxoSmithKline CEO Jean-Pierre Garnier chair of its board of directors. From 2000 to 2008, Garnier was the first CEO of GSK after SmithKline Beecham and Glaxo Wellcome merged and before that he was CEO of SmithKline Beecham. Prior to this he was president of Schering-Plough and after his retirement from GSK, he was CEO of Pierre Fabre Laboratories and chair of Cerenis (US).